KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Debt Ratio (2019 - 2025)

Rigel Pharmaceuticals (RIGL) has 7 years of Debt Ratio data on record, last reported at 0.16 in Q4 2025.

  • For Q4 2025, Debt Ratio fell 60.85% year-over-year to 0.16; the TTM value through Dec 2025 reached 0.16, down 60.85%, while the annual FY2025 figure was 0.16, 60.85% down from the prior year.
  • Debt Ratio reached 0.16 in Q4 2025 per RIGL's latest filing, down from 0.25 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.52 in Q3 2023 and bottomed at 0.09 in Q1 2021.
  • Average Debt Ratio over 5 years is 0.32, with a median of 0.32 recorded in 2022.
  • Peak YoY movement for Debt Ratio: skyrocketed 220.19% in 2022, then plummeted 60.85% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.12 in 2021, then skyrocketed by 146.85% to 0.29 in 2022, then soared by 73.07% to 0.51 in 2023, then fell by 19.69% to 0.41 in 2024, then tumbled by 60.85% to 0.16 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.16 in Q4 2025, 0.25 in Q3 2025, and 0.29 in Q2 2025.